2022 Could Mark a Biotech Resurgence
Venture capital funding has been flooding into the biotech sector this year. And as Jeff Brown looks ahead to...
The Bleeding Edge is the only free newsletter that delivers daily insights and information from the high-tech world as well as topics and trends relevant to investments.
Venture capital funding has been flooding into the biotech sector this year. And as Jeff Brown looks ahead to...
Whether or not you’re an accredited investor, Jeff Brown would love to have you join him tonight at his...
The first half of this year has not gone as Jeff Brown expected, and he knows investors are hurting...
A team of scientists in Switzerland, working with AI for the purposes of drug discovery, turned the AI towards...
Jeff Brown knows these are trying times, and for the past few weeks, has been sharing alternative ways for...
Private investments are no longer the realm of only the uberwealthy, the hedge funds, and the venture capitalists of...
The Bleeding Edge is the only free newsletter that delivers daily insights and information from the high-tech world as well as topics and trends relevant to investments.